Management team

Bob Boyle, Chief Executive officer

Bob Boyle co-founded Sentinel Oncology in 2005 with the aim of discovering new technologies and therapies to treat cancer. Bob has 18 years industrial experience with positions held at Pfizer, (Sandwich, UK: 1993-1997), Cambridge Discovery Chemistry, (1997-2000), Millennium Pharmaceuticals (2000-2003) and Astex Therapeutics (2003-2005).

Bob has extensive leadership experience in pre-clinical research in the field of oncology with an excellent track record of delivering success.

 Stuart Travers, Chief Operating Officer

Stuart Travers co-founded Sentinel Oncology in 2005. Stuart is a Medicinal Chemist by training with a track record of success in multiple therapeutic areas and specifically in Oncology research. With 20 years industrial experience, he has worked in both large pharma (GSK, UK: 1989-1997) and more recently in biotechnology sectors (Cambridge Discovery Chemistry, Millennium Pharmaceuticals, Paradigm Therapeutics: 1997-2005) where Stuart has held a number of senior management roles.